Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Rapid, Sensitive and Specific Method for Quantifying Calr Mutant Allele Burden in Persons with Myeloproliferative Neoplasms

Jiao Zhou, Qiumei Yao, Robert Peter Gale, MD PhD DSc, Jinlan Li, Lingdi Li, Ning Li, Shanshan Chen, Guorui Ruan

Blood (2015) 126 (23): 5210.

https://doi.org/10.1182/blood.V126.23.5210.5210

Published: 2015

Journal Articles

Treatment Outcome and Prognostic Model for Stage IE/IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Retrospective Study in a Cohort of 305 Patients with Long Term Follow-up

Yuankai Shi, MD PhD, Bo Jia, Xiaohui He, MD, Youwu Shi, Mei Dong, MD, Jianliang Yang, MD, Liqiang Zhou, MD, Shengyu Zhou, MD, Peng Liu, MD, Yan Qin, MD, Sheng Yang, MD, Hua Lin, MD, Lin Gui, MD, Changgong Zhang, MD, Lin Wang, MD, Shanshan Chen, MD, Puyuan Xing, MD, Hongnan Mo, MD, Mingzhe Han, MD

Blood (2015) 126 (23): 2718.

https://doi.org/10.1182/blood.V126.23.2718.2718

Published: 2015

Journal Articles

IKZF1 Status As an Independent Prognostic Marker in Adult Common B-Cell Acute Lymphoblastic Leukemia

Qiumei Yao, Kaiyan Liu, Bing Jiang, Yanrong Liu, Qian Jiang, Hao Jiang, Xiaohui Zhang, Shanshan Chen, Xiaojun Huang, Lanping Xu, Guorui Ruan

Blood (2014) 124 (21): 1075.

https://doi.org/10.1182/blood.V124.21.1075.1075

Published: 2014

Journal Articles

Efficacy Analysis With Imatinib Monotherapy Was Superior To Allogeneic Hematopoietic Stem Transplantation In Pediatric Patients With Chronic Phase Of Chronic Myelogenous Leukemia

Hao Jiang, Daihong Liu, Lanping Xu, Kaiyan Liu, Shanshan Chen, MD, Bin Jiang, MD, Qian Jiang, Huan Chen, Yuhong Chen, Wei Han, MD, Xiaohui Zhang, Yazhen Qin, Yueyun Lai, Yanrong Liu, MD, PhD, Xiaojun Huang

Blood (2013) 122 (21): 4035.

https://doi.org/10.1182/blood.V122.21.4035.4035

Published: 2013

Journal Articles

Comparison of Response Over 6 Years Between Patients with Chronic Myeloid Leukemia Who Received Imatinib as Initial Therapy and Those Who Received Imatinib as Secondary Therapy.

Hao Jiang, MD, Xiaojun Huang, MD, PhD, Shanshan Chen, MD, Bin Jiang, Qian Jiang, PhD, Yazhen Qin, Yueyun Lai

Blood (2009) 114 (22): 4281.

https://doi.org/10.1182/blood.V114.22.4281.4281

Published: 2009

NARROW

A Rapid, Sensitive and Specific Method for Quantifying Calr Mutant Allele Burden in Persons with Myeloproliferative Neoplasms

Treatment Outcome and Prognostic Model for Stage IE/IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Retrospective Study in a Cohort of 305 Patients with Long Term Follow-up

IKZF1 Status As an Independent Prognostic Marker in Adult Common B-Cell Acute Lymphoblastic Leukemia

Efficacy Analysis With Imatinib Monotherapy Was Superior To Allogeneic Hematopoietic Stem Transplantation In Pediatric Patients With Chronic Phase Of Chronic Myelogenous Leukemia

Comparison of Response Over 6 Years Between Patients with Chronic Myeloid Leukemia Who Received Imatinib as Initial Therapy and Those Who Received Imatinib as Secondary Therapy.

Email alerts

ASH Publications

American Society of Hematology

A Rapid, Sensitive and Specific Method for Quantifying Calr Mutant Allele Burden in Persons with Myeloproliferative Neoplasms

Treatment Outcome and Prognostic Model for Stage IE/IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Retrospective Study in a Cohort of 305 Patients with Long Term Follow-up

IKZF1 Status As an Independent Prognostic Marker in Adult Common B-Cell Acute Lymphoblastic Leukemia

Efficacy Analysis With Imatinib Monotherapy Was Superior To Allogeneic Hematopoietic Stem Transplantation In Pediatric Patients With Chronic Phase Of Chronic Myelogenous Leukemia

Comparison of Response Over 6 Years Between Patients with Chronic Myeloid Leukemia Who Received Imatinib as Initial Therapy and Those Who Received Imatinib as Secondary Therapy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only